Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-479-2 | CAS number: 650-51-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Test method was similar to OECD 409 guideline, but only three animals of each sex were used per dose. No GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 970
- Report date:
- 1970
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 409 (Repeated Dose 90-Day Oral Toxicity Study in Non-Rodents)
- Deviations:
- yes
- Remarks:
- (only three animals of each sex were used per dose).
- GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- TCA
- EC Number:
- 211-479-2
- EC Name:
- TCA
- Cas Number:
- 650-51-1
- Molecular formula:
- C2HCl3O2.Na
- IUPAC Name:
- trichloroacetic acid
- Details on test material:
- - Name of test material (as cited in study report): NaTA
Constituent 1
Test animals
- Species:
- dog
- Strain:
- Beagle
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 13 months old
- Weight at study initiation: Average: 15.8 kg (15.0-17-7 kg)
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- unchanged (no vehicle)
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 90 days
- Frequency of treatment:
- Daily
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
500 ppm
Basis:
nominal in diet
- Remarks:
- Doses / Concentrations:
2000 ppm
Basis:
nominal in diet
- Remarks:
- Doses / Concentrations:
4000 ppm
Basis:
nominal in diet
- Remarks:
- Doses / Concentrations:
8000 ppm
Basis:
nominal in diet
- No. of animals per sex per dose:
- 3 male and 3 female dogs per group
- Control animals:
- yes, concurrent no treatment
Examinations
- Observations and examinations performed and frequency:
- During all the test period, general clinical observations were made once a day (signs of morbidity and mortality, food consumption). The body weight was recorded once a week. At the end of the study blood and urine analysis, and the macro- and microscopic examination of the organs were made.
- Sacrifice and pathology:
- GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Mortality:
- mortality observed, treatment-related
- Body weight and weight changes:
- effects observed, treatment-related
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Haematological findings:
- effects observed, treatment-related
- Gross pathological findings:
- effects observed, treatment-related
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
Effect levels
- Dose descriptor:
- NOEL
- Effect level:
- 500 ppm
- Sex:
- male/female
- Basis for effect level:
- other: From 2000 ppm upwards effects were observed in mortality, body weights, haematology, urinalysis, gross pathology and histopathology.
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
The male animals were significantly more affected by the administration of sodium trichloroacetate than the female. Five male dogs from the two highest dose groups did not survive the experiment and they had to be humanely killed. One female died intercurrently of pleuritis. All dogs in groups from 2000 ppm upwards showed a body weight reduction. With the exception of the 500 ppm dose, all treated animals showed anemia and white cell counts disorders. In groups from 2000 ppm upwards, changes in liver and heart muscles were recorded. From 4000 ppm upwards atrophy of skeletal muscles occurred. It was also observed damage to spermatogenesis in animals from the 2000 ppm group upwards. Urinalysis of the males from the 4000 ppm and 8000 ppm groups killed during the study revealed positive protein and bilirrubin reactions.
Applicant's summary and conclusion
- Conclusions:
- Based on the results, the no effect level in this study was 500 ppm (approximately 30 mg sodium trichloroacetate/kg bw/day).
- Executive summary:
Sodium trichloroacetate was studied in a subchronic toxicity experiment for 90 days. The substance was administered daily in food to three male and three female beagle dogs at four dose levels (500, 2000, 4000 and 8000 ppm). Another group with the same number of animals was used as a control group. The male animals were significantly more affected by the administration of sodium trichloroacetate than the female. Five male dogs from the two highest dose groups did not survive the experiment and they had to be humanely killed. One female died intercurrently of pleuritis. All dogs in groups from 2000 ppm upwards showed a body weight reduction. With the exception of the 500 ppm dose, all treated animals showed anemia and white cell counts disorders. In groups from 2000 ppm upwards, changes in liver and heart muscles were recorded. From 4000 ppm upwards atrophy of skeletal muscles occurred. It was also observed damage to spermatogenesis in animals from the 2000 ppm group upwards. Urinalysis of the males from the 4000 ppm and 8000 ppm groups killed during the study revealed positive protein and bilirrubin reactions. Based on these results, the no-effect-level in this study was 500 ppm (approximately 30 mg sodium trichloroacetate/kg bw/day).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.